Altered renal tubular expression of the complement inhibitor Crry permits complement activation after ischemia/reperfusion

被引:136
|
作者
Thurman, JM
Ljubanovic, D
Royer, PA
Kraus, DM
Molina, H
Barry, NP
Proctor, G
Levi, M
Holers, VM
机构
[1] Univ Colorado, Hlth Sci Ctr, Div Nephrol & Hypertens, Dept Med, Denver, CO 80262 USA
[2] Univ Zagreb, Univ Hosp Dubrava, Dept Pathol, Zagreb, Croatia
[3] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA
来源
JOURNAL OF CLINICAL INVESTIGATION | 2006年 / 116卷 / 02期
关键词
D O I
10.1172/JCI24521
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Ischemia/reperfusion (I/R) of several organs results in complement activation, but the kidney is unique in that activation after I/R occurs only via the alternative pathway. We hypothesized that selective activation of this pathway after renal I/R could occur either because of a loss of complement inhibition or from increased local synthesis of complement factors. We examined the relationship between renal complement activation after I/R and the levels and localization of intrinsic membrane complement inhibitors. We found that loss of polarity of complement receptor I-related protein y (Crry) in the tubular epithelium preceded activation of the alternative pathway along the basolateral aspect of the tubular cells. Heterozygous gene-targeted mice that expressed lower amounts of Crry were more sensitive to ischemic injury. Furthermore, inhibition of Crry expressed by proximal tubular epithelial cells in vitro resulted in alternative pathway-mediated injury to the cells. Thus, altered expression of a complement inhibitor within the tubular epithelium appears to be a critical factor permitting activation of the alternative pathway of complement after I/R. Increased C3 mRNA and decreased factor H mRNA were also detected in the outer medulla after I/R, suggesting that altered synthesis of these factors might further contribute to complement activation in this location.
引用
收藏
页码:357 / 368
页数:12
相关论文
共 50 条
  • [1] Loss of tubular basolateral polarization of the complement inhibitor Crry permits activation of the alternative complement pathway in the kidney after ischemia/reperfusion
    Thurman, JM
    Ljubanovic, D
    Kraus, DM
    Song, WC
    Molina, H
    Holers, VM
    [J]. MOLECULAR IMMUNOLOGY, 2004, 41 (2-3) : 318 - 319
  • [2] Reduced expression of the complement inhibitor Crry on the surface of injured renal tubular epithelial cells causes complement activation
    Renner, Brandon
    Coleman, Kathrin
    Molina, Hector
    Holers, Michael
    Thurman, Joshua
    [J]. MOLECULAR IMMUNOLOGY, 2008, 45 (16) : 4148 - 4148
  • [3] The complement inhibitor Crry is critical for the prevention of complement activation on murine renal tubular epithelial cells
    Renner, Brandon
    Coleman, Kathrin E.
    Amura, Claudia
    Molina, Hector
    Holers, V. Michael
    Thurman, Joshua M.
    [J]. MOLECULAR IMMUNOLOGY, 2010, 47 (13) : 2292 - 2293
  • [4] Alteration in complement inhibitor expression precedes activation of the alternative complement pathway in the kidney after ischemia/reperfusion
    Thurman, JM
    Ljubanovic, D
    Holers, VM
    [J]. FASEB JOURNAL, 2003, 17 (07): : C109 - C109
  • [5] Complement activation after renal ischemia/reperfusion follows loss of polarity of a tubular epithelial complement inhibitor away from the critical site of injury.
    Thurman, JM
    Ljubanovic, D
    Holers, M
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 636A - 636A
  • [6] The Complement Inhibitors Crry and Factor H Are Critical for Preventing Autologous Complement Activation on Renal Tubular Epithelial Cells
    Renner, Brandon
    Coleman, Kathrin
    Goldberg, Ryan
    Amura, Claudia
    Holland-Neidermyer, Amanda
    Pierce, Kathryn
    Orth, Heather N.
    Molina, Hector
    Ferreira, Viviana P.
    Cortes, Claudio
    Pangburn, Michael K.
    Holers, V. Michael
    Thurman, Joshua M.
    [J]. JOURNAL OF IMMUNOLOGY, 2010, 185 (05): : 3086 - 3094
  • [7] Crry-Ig, a complement activation inhibitor, protects mice from ischemia/reperfusion (IR) induced intestinal injury
    Fleming, SD
    Rehrig, ST
    Guthridge, J
    Holers, VM
    Shea-Donohue, T
    Tsokos, G
    [J]. FASEB JOURNAL, 2000, 14 (06): : A1201 - A1201
  • [8] Labile Heme Aggravates Renal Inflammation and Complement Activation After Ischemia Reperfusion Injury
    Wang, Li
    Vijayan, Vijith
    Jang, Mi-Sun
    Thorenz, Anja
    Greite, Robert
    Rong, Song
    Chen, Rongjun
    Shushakova, Nelli
    Tudorache, Igor
    Derlin, Katja
    Pradhan, Pooja
    Madyaningrana, Kukuh
    Madrahimov, Nodir
    Braesen, Jan Hinrich
    Lichtinghagen, Ralf
    van Kooten, Cees
    Huber-Lang, Markus
    Haller, Hermann
    Immenschuh, Stephan
    Gueler, Faikah
    [J]. FRONTIERS IN IMMUNOLOGY, 2019, 10
  • [9] Complement and renal ischemia-reperfusion injury
    Bonventre, JV
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 38 (02) : 430 - 433
  • [10] Overexpression of the complement inhibitor Crry prolongs renal allograft survival.
    Cunningham, PN
    Wang, Y
    Guo, RQ
    Quigg, RJ
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 13A - 13A